Loading patent…
AssigneeQomplx LLC
InventorsJason Crabtree, Richard Kelley, Jason Hopper, David Park
Estimating the term…
The proposed AI drug discovery platform represents a new approach to pharmaceutical research and development, integrating cutting-edge artificial intelligence and machine learning technologies across the entire drug discovery pipeline. This comprehensive system leverages multi-modal data integration, quantum-classical hybrid computing, environmental factor analysis, and digital twin simulations to address the complexities of drug discovery and development. By combining advanced predictive modeling, generative design, and virtual clinical trial capabilities, the platform aims to significantly accelerate the identification and optimization of novel therapeutic compounds while improving safety and efficacy predictions. The system's modular architecture incorporates state-of-the-art techniques in protein design, biomarker discovery, and personalized medicine, enabling a more holistic and precise approach to drug development.
A computing system for multi-scale biological analysis employing an artificial intelligence-based platform, the computing system comprising:
A computer-implemented method executed on an artificial intelligence-based platform for multi-scale biological analysis, the computer-implemented method comprising:
A system for multi-scale biological analysis employing an artificial intelligence-based platform, comprising one or more computers with executable instructions that, when executed, cause the system to:
Non-transitory, computer-readable storage media having computer-executable instructions embodied thereon that, when executed by one or more processors of a computing system employing artificial intelligence-based platform for multi-scale biological analysis, cause the computing system to:
Dependencies are inferred from the claim text.